Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Robert Paull - aVenture Research

Robert Paull

AddedFeb 14, 2024

UpdatedOct 19, 2026

Robert Paull

Robert Paull

Co-Founder, Lux Capital

Robert Paull's Career

Zelda Ventures

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Investment FirmPortola Valley, CA, US

Advisor

Jan 2023 – present

Outsized Ventures

Investment FirmLondon, Greater London, GB

Advisor

Dec 2021 – present

Lux Capital

Investment FirmNew York City, NY, US

Venture Partner

2014 – present

Co-Founder

2000 – present

Kyruus Health

$183.3MBoston, MA, US

Board Member· Board

2013 – present

Sabanci Climate Ventures

Investment FirmAustin, TX, US

Senior Advisor

Mahana Therapeutics

$61M

Chief Executive Officer

Jan 2018 – 2020

Bill & Melinda Gates Foundation

Non-ProfitSeattle, WA, US

Advisor

Oct 2010 – Jun 2014

KALA BIO

PublicArlington, MA, US

Treasurer

Jul 2009 – Jun 2012

President

Jul 2009 – Jun 2012

Board Director

Jul 2009 – Jun 2012

Genocea Biosciences

$520.5MCambridge, MA, US

Founding CEO

Aug 2006 – Feb 2009

People Similar to Robert Paull

Graham GardnerBoard Member · Kyruus Health

Alexander Saint-AmandCo-Founder · Topography Health

Boris NikolicManaging Director · Biomatics Capital Partners

Parag ShahCo-Founder & CEO · K2 HealthVentures

Kelly HolmanCo-Founder · Genesys Capital

Recent news

Zelda Ventures’ new pre-seed fund backs serial entrepreneursTechCrunch · 2023

Similar to Zelda Ventures

Zygote VenturesBerkeley, CA, USest. 2009Zygote VenturesBerkeley, CA, US · est. 2009

Zygote Ventures LLC: A US-based venture capital firm specializing in seed, early, and growth stage investments.

Investment Firm5

Zelkova VenturesMiami, FL, USest. 2008Zelkova VenturesMiami, FL, US · est. 2008

Zelkova Ventures LLC: A US-based venture capital firm investing in early-stage and pre-revenue companies.

Investment Firm7

StartVentureSan Francisco, CA, USest. 2010StartVentureSan Francisco, CA, US · est. 2010

StartVenture Capital: A leading seed-stage investment firm, providing funding and guidance to ambitious founders, from seed to Series A.

Investment Firm30

ZillionizePalo Alto, CA, USest. 2011ZillionizePalo Alto, CA, US · est. 2011

Zillionize: A self-funded, seed-stage investor passionate about empowering future-focused startups.

Investment Firm9

Similar to Mahana Therapeutics

metaMe HealthChicago, IL, USDigital Therapeuticsest. 2016metaMe HealthChicago, IL, US · est. 2016

MetaMe Health: FDA-cleared digital therapeutics provider for gastrointestinal conditions.

Accession TherapeuticsAccession Therapeutics

Series D · $107M

Theranicaest. 2016Theranicaest. 2016

Theranica develops prescription digital therapeutics, including the Nerivio wearable for drug-free migraine treatment.

Manistee TherapeuticsConcord, MA, USest. 2021Manistee TherapeuticsConcord, MA, US · est. 2021

Concord-based medical organization operating in Stealth mode.

Series A · $9.5M5

Leadership at Outsized Ventures

Isabel FoxCo-Founder

Lomax WardCo-Founder

Similar to Outsized Ventures

Outward VCLondon, Greater London, GBest. 2017Outward VCLondon, Greater London, GB · est. 2017

Outward VC: Investing in early-stage fintech shaping the future of financial services in the EU & UK.

Investment Firm9

Fathom CapitalSan Francisco, CA, USest. 2017Fathom CapitalSan Francisco, CA, US · est. 2017

Fathom Capital: An early-stage VC firm specializing in enterprise applications and IT infrastructure.

Investment Firm1

Outset CapitalSan Francisco, CA, USest. 2021Outset CapitalSan Francisco, CA, US · est. 2021

Outset Capital, founded in 2021, is a San Francisco-based financial services firm.

Investment Firm2

Start VenturesLisbon, PTest. 2023Start VenturesLisbon, PT · est. 2023

Start Ventures Ltd, a UK-based venture capital firm, specializes in owning non-banking securities.

Investment Firm5

Recent news

Sequoia-backed Catalyst raises $30 million to build AI trading agents for everyday investorsFortune · 2026

Andreessen- and Thiel-backed defense startup opens U.S. missile factory as it exits stealthCNBC Tech · 2026

XDOF, just 3 months out of stealth, is in talks for a Series B at a $1.2B valuationTechCrunch · 2026

Leadership at Lux Capital

Josh WolfePartner and Co-Founder

David YangPartner

Saunaz MoradiPartner, Communications

Lan JiangPartner

Thomas ReardonVenture Partner

Tracie RotterPartner, Platform

Similar to Lux Capital

Luxor Capital GroupNew York City, NY, USest. 2002Luxor Capital GroupNew York City, NY, US · est. 2002

New York-based Luxor Capital Group, founded in 2002, offers diverse hedge fund investments and advisory services.

Investment Firm30

Recent news

RevSpring Acquires Kyruus Health for Connected Care JourneyRevSpring · 2025

Kyruus Announces Acquisition of Epion HealthKyruus Health · 2022

Kyruus Completes Acquisition of HealthSparqKyruus Health · 2021

Leadership at Kyruus Health

Julie YooCo-Founder

Bryan RobertsBoard Member

Sam BraschBoard Member

Rob CoppedgeBoard Member

Gary GottliebBoard Member

Bob HigginsBoard Member

Similar to Kyruus Health

Better HealthcareNew York City, NY, USHealthcare Softwareest. 1988Better HealthcareNew York City, NY, US · est. 1988

Better Healthcare: A tech provider driving growth and patient-provider connections in healthcare.

Seed · $3.4M34

Leadership at Bill & Melinda Gates Foundation

Bill GatesCo-Founder

Melinda GatesBoard Member

Sue Desmond-HellmannCEO

Julie SunderlandManaging Director

Gabriel JonesAdvisor

Similar to Bill & Melinda Gates Foundation

Foundation For A Better WorldSan Francisco, CA, USGlobal Development, Medical Researchest. 2013Foundation For A Better WorldSan Francisco, CA, US · est. 2013

Supporting medical research, education, and global development for a better world.

Leadership at KALA BIO

Justin HanesBoard Member

Mark BlumenkranzBoard Member

Mark IwickiBoard Member

Andrew KovenBoard Member

Similar to KALA BIO

KaloBios PharmaceuticalsSouth San Francisco, CA, USAntibodies, Pharmaceuticalsest. 2000KaloBios PharmaceuticalsSouth San Francisco, CA, US · est. 2000

KaloBios Pharmaceuticals: Advancing biopharmaceutical solutions for rare diseases and specific cancers.

Public · $56M11

Leadership at Genocea Biosciences

George SiberBoard Member

Chip ClarkBoard Member

Ken BateBoard Member

Similar to Genocea Biosciences

GeoVax LabsSmyrna, GA, USVaccinesest. 2001GeoVax LabsSmyrna, GA, US · est. 2001

GeoVax Labs Inc.: A biotech firm specializing in the development and commercialization of vaccines for HIV-1 and other diseases.

Public · $28M14

Geneos TherapeuticsPlymouth Meeting, PA, USCancer Treatmentest. 2016Geneos TherapeuticsPlymouth Meeting, PA, US · est. 2016

Geneos Therapeutics: Pioneering personalized immunotherapy for effective cancer treatment.

Series A · $49.5M30

GlobeimmuneLouisville, CO, USVaccinesest. 1995GlobeimmuneLouisville, CO, US · est. 1995

GlobeImmune operates as an immunotherapy subsidiary of ImmunityBio, developing yeast-based therapeutic vaccines for cancer and infectious diseases.

AgenusLexington, MA, USImmuno-Oncology Productsest. 1994AgenusLexington, MA, US · est. 1994

Agenus Inc., a global biotech firm, develops and manufactures immuno-oncology products for enhanced patient care.

Public · $271.1M533

L Capital PartnersNew York City, NY, USest. 2001

L Capital PartnersNew York City, NY, US · est. 2001

L Capital Partners, a NYC-based $165M fund, invests in healthcare, tech, and energy firms with potential for groundbreaking market products.

Investment Firm30

Founders FundSan Francisco, CA, USest. 2005Founders FundSan Francisco, CA, US · est. 2005

San Francisco venture capital firm Founders Fund manages roughly $17 billion in assets.

Investment Firm50

Longitude CapitalMenlo Park, CA, USest. 2006Longitude CapitalMenlo Park, CA, US · est. 2006

Longitude Capital: A venture capital firm investing in biotech, medtech, and health solutions for improved life quality.

Investment Firm45

Keona HealthChapel Hill, NC, USAppointment Scheduling, Healthcare CRMest. 2011

Keona HealthChapel Hill, NC, US · est. 2011

Keona Health, Inc.: Providing 24/7 call support and online appointment scheduling for healthcare.

Series A · $10.4M29

NexHealthSan Francisco, CA, USHealthcare Softwareest. 2017NexHealthSan Francisco, CA, US · est. 2017

NexHealth: Streamlining healthcare with EHR-integrated solutions for patients, doctors, and developers.

Series C · $177.2M313

Garner HealthNew York City, NY, USHealthcareest. 2019Garner HealthNew York City, NY, US · est. 2019

Garner Health: A tech-driven healthcare platform for data-informed services and doctor search.

Series D · $179.3M201-500 employees

Gordon and Betty Moore FoundationPalo Alto, CA, USEnvironmental Conservation, Patient Care, Scienceest. 2000

Gordon and Betty Moore FoundationPalo Alto, CA, US · est. 2000

Moore Foundation: A non-profit enhancing life quality through environmental conservation, patient care, and science in the US.

Nonprofit112

Michael & Susan Dell FoundationAustin, TX, USEducation, Healthest. 1999Michael & Susan Dell FoundationAustin, TX, US · est. 1999

Private foundation committed to enhancing health and education for children in urban poverty.

Gavi AllianceGeneva, Canton of Geneva, CHImmunization, Vaccinesest. 2000Gavi AllianceGeneva, Canton of Geneva, CH · est. 2000

Gavi, the Vaccine Alliance, is a global health partnership dedicated to increasing immunization access in poor countries.

Cell Care TherapeuticsMonrovia, CA, USBiopharmaceuticalsest. 2014

Cell Care TherapeuticsMonrovia, CA, US · est. 2014

Cell Care Therapeutics: A California-based biopharmaceutical firm specializing in regenerative immunotherapies.

Seed · $5.3M7

Qlaris BioWellesley, MA, USTherapeuticsest. 2019Qlaris BioWellesley, MA, US · est. 2019

Therapeutics firm focusing on high-need areas in debilitating eye diseases.

Series A · $25M9

PMGC HoldingsSan Jose, CA, USSkincare, Therapeuticsest. 2019PMGC HoldingsSan Jose, CA, US · est. 2019

Reactive Medical Labs: Pioneering regenerative skincare solutions through advanced biotechnology since 2019.

Public · $732.5k30